Aberrant cytoplasmic intron retention is a blueprint for RNA binding protein mislocalization in VCP-related amyotrophic lateral sclerosis by Giulia E Tyzack et al.
Aberrant cytoplasmic intron retention is a
blueprint for RNA binding protein
mislocalization in VCP-related amyotrophic
lateral sclerosis
Author Giulia E Tyzack, Jacob Neeves, Hamish Crerar,
Pierre Klein, Oliver Ziff, Doaa M Taha,









Publisher Oxford University Press on behalf of the
Guarantors of Brain.




Creative Commons Attribution 4.0 International(https://creativecommons.org/licenses/by/4.0/)
Aberrant cytoplasmic intron retention is a
blueprint for RNA binding protein
mislocalization in VCP-related amyotrophic
lateral sclerosis
Giulia E. Tyzack,1,2,† Jacob Neeves,1,2,† Hamish Crerar,1,2 Pierre Klein,1,2 Oliver Ziff,1,2
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We recently described aberrantly increased cytoplasmic SFPQ intron-retaining transcripts (IRTs) and concurrent
SFPQ protein mislocalization as new hallmarks of amyotrophic lateral sclerosis (ALS). However, the generalizability
and potential roles of cytoplasmic IRTs in health and disease remain unclear. Here, using time-resolved deep
sequencing of nuclear and cytoplasmic fractions of human induced pluripotent stem cells undergoing motor neuro-
genesis, we reveal that ALS-causing VCP gene mutations lead to compartment-specific aberrant accumulation of
IRTs. Specifically, we identify 4100 IRTs with increased cytoplasmic abundance in ALS samples. Furthermore, these
aberrant cytoplasmic IRTs possess sequence-specific attributes and differential predicted binding affinity to RNA
binding proteins. Remarkably, TDP-43, SFPQ and FUS—RNA binding proteins known for nuclear-to-cytoplasmic mis-
localization in ALS—abundantly and specifically bind to this aberrant cytoplasmic pool of IRTs. Our data are there-
fore consistent with a novel role for cytoplasmic IRTs in regulating compartment-specific protein abundance. This
study provides new molecular insight into potential pathomechanisms underlying ALS and highlights aberrant cyto-
plasmic IRTs as potential therapeutic targets.
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Introduction
Studies have demonstrated that intron retention is more frequent
in mammals than originally recognized, affecting transcripts from
a majority of genes.1–4 It is noteworthy that neural cells, with their
exceptional polarity and compartmentalization, exhibit higher
degrees of intron retention compared with other cell types.1,2,4
Indeed, intron retention is a prominent mode of splicing during
early neuronal differentiation2,5 and plays a functional role in
neuronal homeostasis.1,2,4,6 Intron retention has previously been
implicated in regulating the transcriptome by coupling to RNA
degradation pathways.1,2,7–9 Although intron-retaining transcripts
(IRTs) have predominantly been identified as residing within the
nucleus where they are degraded,1–3 there is an expanding body of
evidence demonstrating the cytoplasmic localization of IRTs.6,10–13
However, their prevalence and role remain understudied. One of
the few studies focusing on a cytoplasmic IRT showed that a
retained intron in the Calm3 transcript determined its
dendritic localization,13 thus revealing an addressing (or ‘zip-cod-
ing’) function of cytoplasmic intron retention. This study raises
the possibility of new roles for intronic RNA sequences beyond a
nuclear function, and suggests that cytoplasmic intron retention
programmes are relevant to human neurological function and
their perturbation, therefore, to disease.
Amyotrophic lateral sclerosis (ALS) is a rapidly progressive
and incurable adult-onset condition, which leads to the relatively
selective degeneration of motor neurons. The molecular patho-
logical hallmark of ALS is a nuclear-to-cytoplasmic mislocaliza-
tion of key RNA binding proteins (RBPs),5,14,15 although the
underlying mechanism for this phenomenon remains elusive.
ALS-causing gene mutations implicate crucial regulators of RNA
processing, which are normally expressed throughout develop-
ment.16,17 This raises the hypothesis that post-transcriptional
changes, including those occurring during neurodevelopment,
may play a pivotal role in the underlying molecular pathogenesis
of ALS. We recently described intron retention as the predomin-
ant splicing event characterizing early stages of motor neuron
lineage restriction from human induced pluripotent stem cells
(hiPSCs), which is perturbed by genetically diverse ALS-causing
mutations.5 However, whether this process affects the nuclear or
cytoplasmic subcellular compartments similarly remains unre-
solved. Few studies have examined compartment-specific intron
retention in differentiated neurons,6,11 and to our knowledge, no
study has comprehensively investigated cytoplasmic intron re-
tention programmes during human motor neurogenesis, nor sys-
tematically characterized the effect of an ALS-causing mutation.
Here, we combine cellular fractionation of hiPSCs undergoing
motor neurogenesis with deep RNA-sequencing (RNA-seq) of 100
million paired end reads per sample to gain insight into the mo-
lecular ‘logic’ governing intron retention programmes in healthy
and disease states. This is a rich resource for researchers across
the disciplines of basic and applied neuroscience, constituting six
time points during motor neurogenesis for four control lines (from
four healthy individuals) and three ALS lines (from two patients
carrying mutations in the VCP gene), which have been fractionated
into nuclear and cytoplasmic samples. Indeed, this resource
allowed us to make important insights into the nature of aberrant
intron retention in a human stem cell model of ALS. Specifically,
we provide a taxonomy for aberrant intron retention based on
nucleocytoplasmic distribution, cis attributes and predicted intron
binding affinities to major RBPs. Remarkably, this revealed 4100
IRT species in the cytoplasm of ALS cultures, suggesting that this
is a more widespread phenomenon than previously recognized.
Furthermore, we confirm direct binding of splicing factor proline
and glutamine rich (SFPQ) protein with SFPQ IRT within the cyto-
plasm of our hiPSC ALS model along with preliminary evidence of
a functional interaction between them. In summary, we have
uncovered a novel class of cytoplasmic IRTs that exhibits predict-
ive value for the nuclear-to-cytoplasmic mislocalization of key
RBPs, a recognized molecular hallmark of ALS.
Materials and methods
Detailed methods are provided in the Supplementary material.
Ethics statement
Informed consent was obtained from all patients and healthy con-
trol subjects in this study. Experimental protocols were all carried
out according to approved regulations and guidelines by UCLH’s
National Hospital for Neurology and Neurosurgery and UCL’s
Institute of Neurology joint research ethics committee (09/0272).
Cell culture
HiPSCs were maintained on GeltrexTM (Life Technologies) with
Essential 8TM Medium (Life Technologies), and passaged using
EDTA (Life Technologies, 0.5 mM). All cell cultures were main-
tained at 37C and 5% CO2. Directed differentiation of hiPSCs to
motor neurons was performed as previously described.18 Details
of the lines used in this study are provided in Supplementary
Table 1. One of the control lines used (Control 3) is commercially
available and was purchased from Thermo Fisher Scientific (cat.
number A18945).
Data availability
All sequence data for this project have been deposited at NCBI
GEO database under accession number GSE152983. Additional
data supporting the findings of this study are available from the
corresponding authors, upon reasonable request.
Results
High coverage RNAseq data from nuclear and
cytoplasmic fractions during human motor
neurogenesis
We analysed high-throughput poly(A) RNAseq data derived from nu-
clear and cytoplasmic fractions of hiPSCs (Day 0), neural precursors
(NPC; Days 3 and 7), ‘patterned’ precursor motor neurons (pMN; Day
14), post-mitotic but electrophysiologically immature motor neurons
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(MN; Day 22), and electrophysiologically active motor neurons
(mMNs; Day 35). The cellular material was derived from four healthy
controls and two ALS patients with VCP mutations: R155C and
R191Q, hereafter termed VCPmu (Fig. 1A) [95 samples from six time
points and two genotypes (healthy and VCPmu-related ALS); four
clones from four different healthy controls and three clones from
two VCPmu patients]. Further details of the samples sequenced can be
found in Supplementary Table 1 and details of the RNAseq quality
control in Supplementary Table 2. Cells from each stage of differenti-
ation were characterized as previously reported.18 The efficiency of
cellular fractionation was assessed both at protein and RNA levels.
The predominantly nuclear proteins histone H3 and PSPC1 were
highly enriched in the nuclear fraction, whereas the cytosolic en-
zyme GAPDH was mainly detected in the cytoplasm (Fig. 1B).
Similarly, the presence of GAPDH intronic RNA was negligible in the
cytoplasm, suggesting that leakage of RNA from the nucleus to the
cytoplasm due to the fractionation protocol was minimal.
Importantly, the efficiency of fractionation was comparable between
control and VCPmu lines. Singular value decomposition (SVD) analysis
of 18 834 reliably expressed genes across the 95 samples revealed
that developmental stage and cellular fraction were the largest con-
tributors to transcriptome diversity, explaining 41% and 15% of the
variance, respectively. Notably, the VCPmu samples cluster with their
age- and fraction-matched control counterparts (Fig. 1C–E).
Unsupervised hierarchical clustering (Spearman rank correlation and
complete-linkage clustering) of the 95 samples using 18 834 genes
segregated samples by developmental stage rather than genetic
background (Supplementary Fig. 1A).
Widespread aberrant cytoplasmic intron retention
in a human stem cell model of ALS
We previously identified ALS-related aberrant cytoplasmic SFPQ
IRTs and concurrent SFPQ protein mislocalization.5 Here we tested
the hypothesis that aberrant cytoplasmic intron retention is a gener-
alizable transcriptomic phenomenon in ALS. We examined patterns
of splicing using the RNAseq pipeline VAST-TOOLS.19 In line with
our previous study, increased intron retention was the dominant
feature of the splicing programme during early neural differentiation
in both the nucleus and the cytoplasm (Supplementary Fig. 1B–E).
We identified 791 nuclear (527 included and 264 skipped) and 329
cytoplasmic (204 included and 125 skipped) alternative splicing
events that are statistically significantly different between VCPmu
and control samples in at least one time point (Supplementary Fig.
1F and G). In line with our previous study, the majority of inclusion
events between VCPmu and control samples were retained introns
(Fig. 1F, top). We found that these events peak in pMNs (Day 14 in
vitro, DIV = 14) (Fig. 1F, bottom) when we observe a coincident de-
crease in expression of splicing factors (Fig. 1G and Supplementary
Fig. 1H); most notable are the 112 aberrant intron retention events in
the cytoplasmic fraction. Given that most VCP-driven aberrant
retained intron events peak at Day 14, we subsequently chose to
focus on this time point in the following analysis. Collectively, these
findings demonstrate that aberrant cytoplasmic intron retention is a
widespread phenomenon in VCP mutation-related ALS that occurs
at an early stage during motor neurogenesis.
A nucleocytoplasmic taxonomy for aberrant IRTs
We next manually curated the list of nuclear and cytoplasmic VCP
mutation-related aberrant intron retention events, focusing on
pMNs (DIV = 14). We identified three categories of aberrant IRTs in
VCPmu cultures: (i) 237 predominantly in the nucleus; (ii) 63 in both
the nucleus and the cytoplasm; and (iii) 49 predominantly in the
cytoplasm (Fig. 2A and Supplementary Tables 3–5). Gene ontology
functional enrichment analysis showed the specific biological asso-
ciation of affected transcripts, including cell cycle for the predomin-
antly nuclear IRTs and protein localization for those that are
predominantly cytoplasmic (Fig. 2B). To address whether these IRTs
exist in motor neurons carrying other ALS causing mutations,
including in FUS and SOD1, we probed external whole-cell RNAseq
datasets and confirmed the presence of aberrant IRTs in these two
genetically diverse forms of ALS. Notably the SOD1 data are derived
from isogenic pairs and further allow us to confirm that the IRTs
observed are mutation-dependent. We found that although our
high-confidence set of 349 aberrant IRTs are also generally affected
in FUS and SOD1 mutant motor neurons, the pool of 49 IRTs that is
predominantly affected in the cytoplasm of VCP mutants exhibits
the strongest effect in both FUS and SOD1 mutant motor neurons
(Fig. 2C and D). Next, looking at the cytoplasmic abundance of the
IRTs relative to the spliced transcripts, we found that the IRTs ac-
count for 40% of the absolute amount of transcript in the cyto-
plasm of VCP mutant cultures compared to 20% in the cytoplasm
of control samples. This result indicates that the cytoplasmic IRTs
abound in our iPSC model and are significantly increased by ALS-
causing VCP mutations (Supplementary Fig. 2A). We previously iden-
tified aberrant intron retention in SFPQ in VCPmu cultures at an early
stage of motor neuron development,5 which we validated here again
by RNAseq and RT-PCR (Fig. 2E and F and Supplementary Fig. 2B).
Importantly, we validated three further IRTs (OGT, TUSC3 and DDX39)
using RT-PCR, where we not only confirmed the increase in intron re-
tention ratio (Supplementary Fig. 2C), but also demonstrated an in-
crease in cytoplasmic abundance of these IRTs (Fig. 2G and
Supplementary Fig. 2D–E). This finding was present when normaliz-
ing using either cell compartment specific or whole cell housekeeping
genes (Fig. 2G and Supplementary Fig. 2C–E, respectively). The finding
that a large number of IRTs, including SFPQ, OGT, TUSC3 and DDX39,
exhibit a specific increase in cytoplasmic abundance in VCPmu cul-
tures suggests that VCP mutations lead to aberrant nuclear export
and/or cytoplasmic stabilization of a specific class of IRTs, potentially
underlying stereotyped cellular dysfunction as a consequence.
Aberrant predominantly cytoplasmic IRTs
abundantly bind RBPs
Prior studies have shown that retained introns are on average shorter
and more G/C rich.2,22,23 Strikingly, here we found that only the pre-
dominantly nuclear aberrantly retained introns exhibit these features.
In complete contrast, aberrantly retained introns within the cyto-
plasm (including both those present within the nucleus and cyto-
plasm, and those in the cytoplasm predominantly) are on average
longer and have lower GC content (Fig. 3A and B). Furthermore, the
predominantly nuclear aberrant IRTs correlate with a cytoplasmic de-
crease in gene expression of their non-intron-retaining counterparts:
this is consistent with prior observations showing that nuclearly
detained IRTs reduce the level of gene expression.2 Conversely, IRTs
found in the cytoplasm correlate with increased gene expression
within the nucleus (Supplementary Fig. 2F). Importantly, this suggests
that previously reported features2,22,23 discriminate nuclearly detained
IRTs from cytoplasmic ones. Two additional features further discrim-
inate cytoplasmic-predominant events from those found in both com-
partments: (i) a high conservation score (Fig. 3C); and (ii) a greater
abundance of RBP crosslinking events in the predominantly cytoplas-
mic retained introns26,27 (Fig. 3D).
Aberrant cytoplasmic IRTs are a blueprint for RBP
mislocalization in VCP-related ALS
The finding that cytoplasmic aberrant IRTs abundantly bind to RBPs
raises the hypothesis that this interaction drives hallmark RBP
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Figure 1 Time-resolved cellular fractionation and RNA sequencing during human motor neurogenesis reveals widespread Aberrant cytoplasmic in-
tron retention is a blueprint for RNA binding protein mislocalization in VCP-related ALS. (A) Schematic depiction of the iPSC differentiation strategy
for motor neurogenesis. Arrows indicate sampling time points in days when cells were fractionated into nuclear and cytoplasmic compartments
prior to deep [poly(A)] RNA sequencing. Four iPSC clones were obtained from four different healthy controls and three iPSC clones from two ALS
patients with VCP mutations: R155C and R191Q; hereafter termed VCPmu. NPCs = neural precursors; pMN = ‘patterned’ precursor motor neurons (ven-
tral spinal cord); MN = post-mitotic but electrophysiologically inactive motor neurons; mMN = electrophysiologically active motor neurons. (B)
Representative QC data for fractionation of samples at DIV = 14 at protein level (western blot, top) and RNA level [quantitative (q)PCR, bottom]. In the
western blot, histone H3 and PSPC1 were chosen as protein markers for the nuclear faction, and GAPDH was used as a cytosolic marker. In the qPCR,
the ratio between intronic and exonic GAPDH sequences was measured in both fractions to exclude the leakage of nuclear RNA into the cytosolic
fraction due to disruption of nuclei during the fractionation. Data are expressed as mean ± standard deviation (SD) from four lines per group. (C)
Singular value decomposition (SVD)performed on normalized 18 834 gene expression values across 95 samples. Samples are plotted by their coordi-
nates along PC1 (41% of variance) and PC2 (15% of variance). Colours of data-points indicate similar time in culture: iPSC (dark blue), DIV = 3 (blue;
NPC1), DIV = 7 (light blue; NPC2), DIV = 14 (grey; pMN), DIV = 22 (light green; MN) and DIV = 35 (dark green; eMN). (D) Same as C with colours of data-
points indicating similar cellular fractions: nuclear fraction (gold) and cytoplasmic fraction (blue). (E) Same as C with colours of data-points indicating
either control samples (red) or VCPmu samples (blue). (F) Top: Pie charts representing proportions of included splicing events in VCPmu at all time
points of motor neurogenesis compared with age-matched control samples in nuclear (top chart) and cytoplasmic (bottom chart) fractions. Total num-
ber of events are indicated above the chart. Alt5 and Alt3 = alternative 50 and 30 UTR; AltEx = alternative exon; MIC = microexons; IR = intron reten-
tion. Bottom: Bar graphs representing the number of retained introns in VCPmu compared to control samples at specific time points during motor
neuron differentiation. Nuclear fraction (gold; left). Cytoplasmic fraction (blue; right). (G) Box plots showing the distributions of cytoplasmic log2 fold-
changes for 72 essential splicing factor genes (Supplementary Table 9) between VCPmu and controls.
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mislocalization events in ALS. Indeed, we previously reported that
the SFPQ IRT and the SFPQ protein itself, which are predicted to avidly
bind to each other, are exported to the cytoplasm thus providing a po-
tential mechanism for SFPQ protein mislocalization in ALS.5 We
therefore further examined the nature of the interaction between
RBPs and aberrant cytoplasmic IRTs using our richer dataset. At least
27 RBPs systematically exhibit statistically significant increased bind-
ing to cytoplasmic-predominant retained introns compared with their
nuclear-predominant counterparts (Fig. 3E). These RBPs form a
densely connected network of experimentally validated interacting
proteins that are enriched in mRNA metabolism functions (Fig. 3F).
The network includes a subset of nine RBPs with known functions in
processing capped intron-containing pre-mRNA, which further impli-
cates disrupted post-transcriptional splicing in ALS pathogenesis.
Importantly, also within this network of RBPs are those that exhibit
hallmark nuclear-to-cytoplasmic mislocalization in ALS: SFPQ (Fig.
3G), transactivation response DNA binding protein 43 (TDP-43), and
FUS (Supplementary Fig. 2H).5,14,15
Figure 2 Aberrant nuclear and cytoplasmic intronic sequences exhibit distinct characteristics. (A) Schematic of our proposed taxonomy for aberrant
IRTs (left) and bar graphs (right) representing the numbers of retained introns in VCPmu compared to control samples at DIV = 14 that are predomin-
antly nuclear (gold), in both the nucleus and cytoplasm (grey), or predominant in cytoplasm (blue). The number of events in each category is indi-
cated above the bar. (B) Bar plots displaying the enrichment scores for GO biological functions of genes that are targeted by each group of aberrantly
retained introns. (C and D) Box plots displaying the distribution of percentage retention for all 349 manually curated retained introns, 237 nuclear
retained introns (gold), 63 cytoplasmic and nuclear retained introns, and 49 cytoplasmic retained introns in control motor neurons (white boxes), FUS
mutant motor neurons (green boxes; C) or SOD1 mutant motor neurons samples (blue boxes; D).20,21 Mutant samples systematically exhibit a higher
proportion of intron retention compared with controls. P-values obtained from linear mixed models accounting for idiosyncratic variations between
the iPSC lines. Data shown as box plots in which the centre line is the median, limits are the interquartile range and whiskers are the minimum and
maximum. (E) Bar graphs quantifying percentage intron retention in SFPQ transcripts at DIV = 0, 3, 7 and 14 in control and VCPmu samples
(mean ±SD; Fisher count test) in the nucleus (left) and cytoplasm (right). (F) Bar graph showing intron retention levels analysed by qPCR at DIV =14 in
control and VCPmu cytosolic fractions for SFPQ and measured by normalizing the levels of SFPQ IRT over the SFPQ expression level for each line. (G)
Abundance of SFPQ IRT in the cytoplasm at DIV = 14 measured by qPCR and normalized over the compartment-specific housekeeping genes NIT1 and
NFX1. In F and G, data are expressed as fold-change over the control group mean; data displayed as bar plots with mean ± SD from four lines per
group, with each data-point representing the average across two technical replicates (*P5 0.05, **P5 0.01, unpaired t-test).
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Figure 3 Cytoplasmic IRTs create a mislocalization-prone environment for bound RBPs. (A–D) Comparison of intron length, GC content (%), conserva-
tion scores and median enrichment for RBP binding sites of the three groups of aberrantly retained introns. Box plots are as shown in Fig. 1. (C and D)
P-values obtained from Mann-Whitney test. All introns in the gene-set targeted by intron retention in VCPmu at DIV = 14 (white). (E) Heat map of the
enrichment score of the crosslinking events in each of the 49 predominantly cytoplasmic aberrant IRTs for 27 RBPs that exhibit significantly higher
enrichment compared to the two other categories of IRTs (i.e. predominantly nuclear and those that are both cytoplasmic and nuclear). (F) Network
of protein–protein interactions for 21 (out of the 27) RBPs for which binding sites are enriched in cytoplasmic aberrant retained introns. Edges repre-
sent experimentally determined protein–protein interactions annotated in the STRING database.24 Nine of these RBPs belong to the ‘Processing of
Capped Intron-Containing Pre-mRNA’ Reactome25 pathway (filled magenta circles) and three are RBPs that exhibit hallmark nuclear-to-cytoplasmic
mislocalization ALS (green circle). Line thickness indicates the strength of data support based on text mining and experiments. (G) Comparison of en-
richment across all genes within each category for SFPQ crosslinking events in the retained introns between the three groups of aberrantly retained
introns. (H) RNA immunoprecipitation (IP) performed on the cytoplasmic lysates from control and VCPmu at DIV = 14 using antibodies for SFPQ or nor-
mal IgG as negative control. Levels of associated mRNA transcripts were analysed by qRT-PCR using primers designed against the indicated targets
(n = 4). See also Supplementary Fig. 3A. (I) Bar graphs showing qRT-PCR analysis of levels of indicated transcripts in total input of cytoplasmic lysates
from DIV = 14 control and VCPmu samples. Values were normalized to the geometric mean of two compartment-specific housekeeping genes, NFX1
and NIT1, before being expressed as fold-change over control group mean. *P5 0.05 Mann-Whitney test, n = 4 lines per group.
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Notably, we have previously demonstrated reduced nuclear-to-
cytoplasmic ratio of SFPQ, FUS and TDP-43 proteins in VCP mutant
hiPSC-derived neural precursors and/or motor neurons.5,15,18,28,29
To contextualize these previous protein mislocalization findings
with our current study, we next sought to examine the mechanis-
tic relationship between RBP function and aberrant accumulation
of IRTs in the cytoplasm, focusing on the interaction between
SFPQ protein and SFPQ IRTs. We first performed RNA immunopre-
cipitation to demonstrate that the SFPQ protein physically inter-
acts with SFPQ IRT (Fig. 3H and Supplementary Fig. 3A). When
considered together with the fact that we also found a higher
abundance of SFPQ IRT in the input from the VCP mutant when
compared to input from the control or the spliced/constitutive
transcripts in either genotype (Fig. 3I), these data are consistent
with an increased specific interaction between SFPQ IRT and SFPQ
protein in VCP mutant cultures compared to control counterparts.
We next knocked down SFPQ protein using an siRNA approach
(Supplementary Fig. 3B and C). We found that while this siRNA-
mediated knockdown resulted in a substantial reduction in ex-
pression of both SFPQ spliced transcript and SFPQ IRT
(Supplementary Fig. 3B, D and E), a significant increase in the SFPQ
intron retention ratio relative to the spliced transcript was
observed (Supplementary Fig. 3F). This result suggests that SFPQ
protein autoregulates its own intron retention, which is consistent
with a recent study reporting significant retention of long introns
upon SFPQ depletion.30,31 Altogether our data lend support to a
model whereby ALS leads to an increase in the abundance of a
class of cytoplasmic IRTs with a large capacity for binding RBPs.
In turn, this may create an environment that encourages nuclear-
to-cytoplasmic mislocalization of IRT-bound RBPs followed by
nuclear loss of function and/or altered function in the cytoplasm
(Fig. 4).
Discussion
Recent studies have demonstrated that intron retention is more
frequent in mammals than previously recognized.1–4 We previous-
ly identified aberrant cytoplasmic intron retention in the SFPQ
transcript across human stem cell models of diverse genetic forms
of ALS (including those caused by mutations in VCP, SOD1 and FUS
genes).5 In the present study, we sought to understand the gener-
alizability of cytoplasmically localized aberrant IRTs in ALS by
combining directed differentiation of patient-specific hiPSCs into
spinal motor neurons with cellular fractionation and deep
[poly(A)] RNA sequencing. We showed that aberrant cytoplasmic
intron retention is indeed a widespread molecular phenomenon in
ALS that comprises at least 112 transcripts including SFPQ.
Furthermore, we specifically demonstrated an increase in the
cytoplasmic abundance of the intronic sequences, suggesting ab-
errant nuclear export and/or cytoplasmic stabilization of a specific
pool of IRTs in VCP mutant samples. Importantly, a significant
overlap of these aberrant events has been previously recapitulated
in RNAseq datasets from terminally differentiated motor neurons
carrying mutations in SOD1 or FUS genes.20,21 Furthermore, the
most significant intron retention event identified in our aforemen-
tioned study, intron 9 of the SFPQ transcript, has been recently
reproduced in human post-mortem tissue from sporadic ALS
cases, demonstrating the predictive power of our hiPSC model.32
To better understand the nature of cytoplasmic IRTs, we cate-
gorized the aberrant intron retention events into three classes
according to their nucleocytoplasmic distribution (predominantly
nuclear, predominantly cytoplasmic and those present in both
compartments). We chose to direct our attention to Day 14 of our
motor neurogenesis protocol as this was where the majority of ab-
errant intron retention events were observed. Retained introns
Figure 4 Schematic of proposed model where cytoplasmic IRT accumulation in ALS leads to protein mislocalization.
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during neurogenesis have previously been shown to exhibit a
highly correlated set of cis features comprising an ‘intron retention
code’ that can reliably discriminate retained from constitutively
spliced introns.2 Examining the cis attributes of the three catego-
ries of IRTs, we found that aberrantly retained introns that are pre-
dominantly in the nucleus of VCP mutant cultures display similar
lengths and GC content to this ‘intron retention code’.2 Intron reten-
tion has been previously implicated in fine-tuning the cellular tran-
scriptome by targeting transcripts to RNA degradation pathways
such as nonsense-mediated decay.1,2,7–9 The retained introns char-
acterized in the aforementioned studies act broadly to reduce the
levels of transcripts that are not required.3,33 Indeed, the category of
predominantly nuclear aberrant IRTs also correlates with reduced
gene expression in our data. Remarkably, however, the two other
categories we identified exhibit an almost opposite effect on their
gene expression levels and thus stimulated further investigation.
Our study further revealed a specific class of cytoplasmic IRTs that
(i) have unique features compared to those reported in previous
studies; and (ii) have conspicuously high affinity for RBPs, including
those that are mislocalized in ALS (TDP43, FUS and SFPQ).5,14,15
These findings raise the hypothesis that a subset of cytoplasmic
IRTs has a distinct role compared to the previously reported IRTs
that regulate gene expression and translation through coupling with
nonsense-mediated decay.2
RNA localization to distinct subcellular compartments has been
shown to regulate spatio-temporal control of protein expression34
but less is known about their role in protein localization. Here we
demonstrate for the first time a direct interaction between SFPQ
protein and SFPQ IRT in the cytoplasm and further show siRNA
SFPQ knockdown-related increase in SFPQ intron retention ratio
relative to the spliced transcript. These data support a model where
nuclear SFPQ binding to its retained intron facilitates splicing under
normal circumstances, which is consistent with a recent study
showing significant retention of long introns upon SFPQ deple-
tion.31 An increase in SFPQ IRT cytoplasmic abundance may then
lead to SFPQ nuclear-to-cytoplasmic mislocalization, SFPQ nuclear
loss-of-function and consequently amplify aberrant splicing of SFPQ
intron 9, which in turn exacerbates SFPQ nuclear loss-of-function.
However, we have not formally excluded the possibility that an in-
crease in SFPQ IRT upon knockdown is caused by differential acces-
sibility or targeting of the SFPQ IRTs by the siRNAs. Therefore,
future experiments should further address the specific role of nu-
clear SFPQ protein in regulating retention of intron 9 within its own
transcript. Altogether we propose that a subset of IRTs aberrantly
accumulate in the cytoplasm and their intronic sequences serve as
‘blueprints’ for the hallmark protein mislocalization events in ALS
by creating a mislocalization-prone environment for their bound
(and otherwise predominantly nuclear) RBPs (Fig. 4). This is rein-
forced by the fact that the RBPs with the largest difference in bind-
ing affinity between the predominantly cytoplasmic versus
predominantly nuclear aberrant intron retention are those known
to be mislocalized in ALS: TDP-43, FUS and SFPQ. However, further
work is needed to definitively resolve the nature of the interaction
between cytoplasmically mislocalized RBPs and cytoplasmic IRTs.
The first systematic characterization of intron retention during
neuronal lineage restriction examined time-resolved RNAseq data
during the differentiation of cortical glutamatergic neurons from
murine embryonic stem cells. This study established that intron re-
tention progressively increases during neuronal differentiation and
downregulates non-physiologically relevant transcripts.2 Drawing
on RNAseq data from our established hiPSC model,18 we subse-
quently reported a transient developmental intron retention pro-
gramme early during neurogenesis from human pluripotent stem
cells.5 It is noteworthy that the majority of studies have focused on
nuclear IRTs and that the importance of cytoplasmic IRTs remains
relatively understudied, particularly in the contexts of neuronal de-
velopment and disease. In the present study we show that a large
proportion of the transcripts exhibiting transient intron retention
during neuronal development are indeed not restricted to the nu-
cleus but transiently localize to the cytoplasm, and that this pool
has strong binding affinity for RBPs. Based on these findings we hy-
pothesize that a subset of neurodevelopmentally-regulated IRTs is
specifically targeted to the cytoplasm where they attract RBPs
through direct interaction leading to a transient decrease in splicing
machinery in the nucleus. This adds a new and interesting complex-
ity to the potential roles of IRTs, including in regulating gene expres-
sion during neuronal development.2 Future studies will directly
assess this hypothesis. In summary, we propose that cytoplasmic-
retained introns function as RNA regulators in the homeostatic con-
trol of RBP localization and that an ALS-related aberrant increase in
cytoplasmic intron retaining transcripts disrupts this process, result-
ing in the hallmark RBP mislocalization phenotypes.
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